Donepezil Hydrochloride Tablets, 23mg

TWi Pharmaceuticals, Inc

Revision date : 2014-11-24

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2014-11-24

Product name

Donepezil Hydrochloride Tablets, 23mg

1.2.1 Relevant identified uses

Therapeutic Category: Treatment for Alzheimer’s disease

Icons in SDS

Company Information

company name

TWi Pharmaceuticals, Inc

e-mail address of the competent person responsible for the Safety Data Sheet

QA.Service@twipharma.com

Section 2

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: Poison Adverse Effects: Adverse effects may include nausea, vomiting, abdominal pain, loss of appetite, diarrhea, constipation, urinary incontinence, sweating, salivation, tremor, unusual tiredness or weakness, difficulty sleeping, headache, dizziness, fainting, mood and mental disturbances, muscle or joint pain, unusual bleeding of bruising, and skin rash. Possible allergic reaction to material if inhaled, ingested or in contact with skin. Overdose Effects: Overdose of cholinesterase inhibitors can lead to cholinergic crisis characterized by severe nausea, vomiting, excessive salivation, sweating, slow heartbeat, low blood pressure, severe muscle weakness, respiratory depression, collapse, convulsions, coma, and death. Acute: Possible eye, skin, gastrointestinal and/ or respiratory tract irritation. Chronic: Possible hypersensitization.

Medical Conditions Generally Aggravated by Exposure

Hypersensitivity to material, peptic ulcers or history of, asthma or obstructive pulmonary disease, cardiovascular conduction disorders, gastrointestinal or urinary tract obstruction, Parkinson's disease, CYPZD6 deficiency, and seizure disorders. Cross Sensitivity: Persons sensitive to piperidine derivatives may be sensitive to this material as well. Target Organs: n/f For additional information on toxicity, see Section 11.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.